AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 55 filers reported holding AQUESTIVE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.02 and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $655,714 | -7.3% | 428,571 | 0.0% | 0.10% | -73.2% |
Q2 2023 | $707,142 | +44.7% | 428,571 | 0.0% | 0.39% | +198.5% |
Q1 2023 | $488,571 | +26.4% | 428,571 | 0.0% | 0.13% | +261.1% |
Q4 2022 | $386,614 | -22.8% | 428,571 | 0.0% | 0.04% | -59.1% |
Q3 2022 | $501,000 | +82.8% | 428,571 | 0.0% | 0.09% | +104.7% |
Q2 2022 | $274,000 | -75.5% | 428,571 | 0.0% | 0.04% | -48.2% |
Q1 2022 | $1,119,000 | -32.9% | 428,571 | 0.0% | 0.08% | -18.6% |
Q4 2021 | $1,667,000 | -10.8% | 428,571 | 0.0% | 0.10% | -38.2% |
Q3 2021 | $1,869,000 | +9.9% | 428,571 | 0.0% | 0.16% | +10.7% |
Q2 2021 | $1,701,000 | -23.7% | 428,571 | 0.0% | 0.15% | -22.8% |
Q1 2021 | $2,229,000 | -2.8% | 428,571 | 0.0% | 0.19% | -44.5% |
Q4 2020 | $2,293,000 | +10.1% | 428,571 | 0.0% | 0.35% | +4.2% |
Q3 2020 | $2,083,000 | 0.0% | 428,571 | 0.0% | 0.33% | -45.2% |
Q2 2020 | $2,083,000 | +108.3% | 428,571 | 0.0% | 0.61% | +237.0% |
Q1 2020 | $1,000,000 | -50.0% | 428,571 | 0.0% | 0.18% | +12.4% |
Q4 2019 | $2,000,000 | – | 428,571 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |